Clinical Feature of Men Who Benefit from Dose Escalation of Naftopidil for Lower Urinary Tract Symptoms: A Prospective Study

Objectives. To examine the feature of men who benefit from dose escalation of naftopidil for lower urinary tract symptoms (LUTSs). Methods. Based on the IPSS, men reporting LUTS were prospectively studied using 50 mg/day of naftopidil for the first 4 weeks; satisfied patients continued its 50 mg/day...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mizusawa, Takaki, Hara, Noboru, Obara, Kenji, Isahaya, Etsuko, Nakagawa, Yuki, Takahashi, Kota
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3095445/
https://ncbi.nlm.nih.gov/pubmed/21603217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/804583
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares